Comparison of Clinical Effects of Temozolomide Single Agent and Combined Doxorubicin in the Treatment of Glioma
- Type
- Retraction
- Notice date
- 7/12/2023 0:00
- Journal
- Journal of Healthcare Engineering
- Publisher
- Hindawi
- Notice DOI
- 10.1155/2023/9837208
- Original paper DOI
- 10.1155/2022/7995385
Reasons
- Concerns/Issues about Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues about Peer Review
- Informed/Patient Consent - None/Withdrawn
- Investigation by Journal/Publisher
- Investigation by Third Party
- Lack of IRB/IACUC Approval and/or Compliance
- Paper Mill
- Computer-Aided Content or Computer-Generated Content
- Unreliable Results and/or Conclusions